LOVASTATIN
Generic: LOVASTATIN
Lupin PharmaceuticalsManufacturer
ORALRoute
LOVASTATINActive Substance
2007-11-01Original Approval
LOVASTATIN is FDA application ANDA078296, sponsored by LUPIN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2019-02-13
Lovastatin Tablets USP, 40 mg, packaged in a) 60-count (NDC 68180-469-07 and b) 100-count (NDC 68180-469-01) bottles, RxCGMP Deviations: Finished product made with lovastatin drug substance that was out of specification
Class III2019-02-19
Lovastatin Tablets USP, 40 mg, packaged in a) 100-count bottles (NDC 68001-316-00) and b)1000-count bottles (NDC 68001-3CGMP Deviations: Finished product made with lovastatin drug substance that was out of specification
Top Reported Reactions
1
DRUG INEFFECTIVE
1,692 reports
2
FATIGUE
1,542 reports
3
NAUSEA
1,406 reports
4
DIARRHOEA
1,282 reports
5
DYSPNOEA
1,233 reports
6
DIZZINESS
1,174 reports
7
PAIN
1,076 reports
8
HEADACHE
1,020 reports
9
ASTHENIA
990 reports
10
FALL
916 reports